Adele Lehane

Contacts

Contact email:adele.lehane@anu.edu.au
Contact phone:+61 2 6125 6970 (Office)
Location:Rm 3.020, Level 3, Linnaeus Building (134)
Centre:Division of Biomedical Science and Biochemistry
Link:ANU Researchers profile

Group membership

Group Leader, Lehane Group - Antimalarial drug action and resistance

Adele Lehane’s PhD (2006-2010) on the mechanism of chloroquine resistance in the malaria parasite was carried out at the ANU. Immediately following her PhD, Adele relocated to Columbia University on an NHMRC Overseas Biomedical Fellowship (2010-2012) before returning to the ANU for the Australia-based years of the fellowship. Adele is currently an ARC DECRA Fellow and a Senior Lecturer at ANU.

Adele uses and develops physiological and biochemical techniques to study the mechanisms of action of, and resistance to, antimalarial drugs. Her most recent research is centred on ion regulation in malaria and Toxoplasma parasites as a source of new drug targets.

Lehane, A.M.1, Dennis, A.S.M.1, Bray, K.O., Li, D., Rajendran, E., McCoy, J.M., McArthur, H.M., Winterberg, M., Rahimi, F., Tonkin, C.J., Kirk, K. and van Dooren, G.G. (2019) Characterization of the ATP4 ion pump in Toxoplasma gondii. J. Biol. Chem. Accepted Feburary 2019. 1Joint first authors

Uboldi, A.D., Wilde, M., McRae, E.A., Stewart, R.J., Dagley, L.F., Yang, L., Katris, N.J., Hapuarachchi, S.V., Coffey, M.J., Lehane, A.M., Botte, C.Y., Waller, R.F., Webb, A.I., Tonkin, C.J. (2018) Protein Kinase A Negatively Regulates Ca2+ signaling in Toxoplasma gondii. PLoS Biology 16, e2005642.

Lawrence, N., Dennis, A.S.M., Lehane, A.M., Ehmann, A., Harvey, P.J., Benfield, A., Cheneval, O., Henriques, S.T., Craik, D.J. and McMorran, B.J. (2018) Novel defense peptides from human platelet factor 4 kill Plasmodium by selective membrane disruption. Cell Chem. Biol. 25, 1140-1150.

Rosling, J.E.O., Ridgway, M.C., Summers, R.L., Kirk, K. and Lehane, A.M. (2018) Biochemical characterization and chemical inhibition of PfATP4-associated Na+-ATPase activity in Plasmodium falciparum membranes. J. Biol. Chem. 293, 13327-13337.

Dennis, A.S.M., Rosling, J.E.O., Lehane, A.M. and Kirk, K. (2018) Diverse antimalarials from whole-cell phenotypic screens disrupt malaria parasite ion and volume homeostasis. Sci. Rep., 8, 8795.

Dennis, A.S.M., Lehane, A.M., Ridgway, M.C., Holleran, J.P. and Kirk, K. (2018) Cell swelling induced by the antimalarial KAE609 (cipargamin) and other PfATP4-associated antimalarials. Antimicrob. Agents Chemother., 62, e00087-18.

McCoy, J.M., Stewart, R.J., Uboldi, A.D., Li, D., Schroder, J., Scott, N.E., Papenfuss, A.T., Lehane, A.M., Foster, L.J. and Tonkin, C.J. (2017) A forward-genetic screen identifies a negative regulator of rapid Ca2+-dependent cell egress in the intracellular parasite Toxoplasma gondii. J. Biol. Chem., 292, 7662-7674.

Hapuarachchi, S.V., Cobbold, S.A., Shafik, S.H., Dennis, A.S., McConville, M.J., Martin, R.E., Kirk, K. and Lehane, A.M. (2017) The malaria parasite’s lactate transporter PfFNT is the target of antiplasmodial compounds identified in whole cell phenotypic screens. PLoS Pathogens 13, e1006180.

Hewitt, S.N., Dranow, D.M., Horst, B.G., Abendroth, J.A., Forte, B., Hallyburton, I., Jansen, C., Baragana, B., Choi, R., Rivas, K.L., Hulverson, M.A., Dumais, M., Edwards, T.E., Lorimer, D.D., Fairlamb, A.H., Gray, D.W., Read, K.D., Lehane, A.M., Kirk, K., Myler, P.J., Wernimont, A., Walpole, C., Stacy, R., Barrett, L.K., Gilbert, I.H. and Van Voorhis, W.C. (2017) Biochemical and structural characterization of selective allosteric inhibitors of the Plasmodium falciparum drug target, prolyl-tRNA-synthetase. ACS Infect. Dis. 3, 34-44.

Van Voorhis, W.C., [81 authors], Kirk, K., [6 authors], Lehane, A.M., [96 authors] and Willis, P.A. (2016) Open source drug discovery with the Malaria Box compound collection for neglected diseases and beyond. PLoS Pathogens 12, e1005763.

Richards, S.N.1, Nash, M.N.1, Baker, E.S., Webster, M.W., Lehane, A.M., Shafik, S.H. and Martin, R.E. (2016) Molecular mechanisms for drug hypersensitivity induced by the malaria parasite's chloroquine resistance transporter. PLoS Pathogens, In press. 1Joint first authors

Veiga, M.I.1, Dhingra, S.K.1, Henrich, P.P., Straimer, J., Gnadig, N., Uhlemann, A., Martin, R.E., Lehane, A.M. and Fidock, D.A. (2016) Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nature Comm. 7, 11553. 1Joint first authors

van Schalkwyk, D.A.1, Nash, M.N.1, Shafik, S.H.1, Summers, R.L., Lehane, A.M., Smith, P.J. and Martin, R.E. (2016) Verapamil-sensitive transport of quinacrine and methylene blue via mutant PfCRT reduces the malaria parasite’s susceptibility to these tricyclic drugs. J. Infect. Dis. 13, 800-810. 1Joint first authors

Petersen, I., Gabryszewski, S.J., Johnston, G.L., Dhingra, S.K., Ecker, A., Lewis, R.E., Almeida, M.J., Straimer, J., Henrich, P.H., Palatulan, E., Johnson, D.J., Coburn-Flynn, O., Sanchez, C., Lehane, A.M., Lanzer, M. and Fidock, D.A. (2015) Balancing drug resistance and growth rates via compensatory mutations in the P. falciparum chloroquine resistance transporter. Mol. Microbiol. 97, 381-395.

Marchetti, R.V., Lehane, A.M., Shafik, S.H., Winterberg, M., Martin, R.E. and Kirk, K. (2015) A lactate and formate transporter in the intraerythrocytic malaria parasite, Plasmodium falciparum.  Nature Comm.  6, 6721.

Jiménez-Díaz, M.B., Ebert, D., Salinas, Y., Pradhan, A., Lehane, A.M., Myrand-Lapierre, M., O’Loughlin, K.G., Shackleford, D.M., de Almeida, M.J.L., Carillo, A., Clark, J., Dennis, A.S.M., Diep, J., Deng, X., Duffy, S., Endsley, A.N., Guiguemde, G.F.A., Gomez-Lorenzo, M.G., Holbrook, G., Horst, J., Kim, C., Liu, J., Lee, M.C.S., Matheny, A., Martínez, M.S., Miller, G., Rodriguez-Alejandre, A., Sanz, L., Sigal, M., Spillman, N.J., Stein, P.D., Wang, Z., Zhu, F.,, Waterson, D., Knapp, S., Shelat, A.A., Fidock, D.A., Gamo, F.J., Charman, S.A., Mirsalis, J.C., Ma, H., Ferrer, S., Kirk, K., Angulo-Barturen, I., Kyle, D.E., DeRisi, J.L., Floyd, D.M. and Guy, R.K. (2014) (+)-SJ733: A clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Proc. Natl Acad. Sci. USA.111, E5455- E5462.

Kirk, K. and Lehane, A.M. (2014) Membrane transport in the malaria parasite and its host erythrocyte. Biochem. J. 457, 1-18.

Lehane, A.M., Ridgway, M.C., Baker, E. and Kirk, K. (2014) Diverse chemotypes disrupt ion homeostasis in the malaria parasite. Mol. Microbiol. 94, 327-339.

Teng, R.1, Lehane, A.M.1, Winterberg, M., Shafik, S.H., Summers, R.L., Martin, R.E., van Schalkwyk, D.A., Junankar, P.R. and Kirk, K. (2014) 1H NMR metabolite profiles of different strains of Plasmodium falciparum. Biosci. Rep. 34, e00150. 1Joint first authors

Hrycyna, C.A.1, Summers, R.L.1, Lehane, A.M.1, Pires, M.M., Namanja, H., Bohn, K., Kuriakose, J., Ferdig, M.T., Henrich, P.P., Fidock, D.A., Kirk, K., Chmielewski, J.2 and Martin, R.E.2 (2014) Quinine dimers are potent inhibitors of the Plasmodium falciparum Chloroquine Resistance Transporter and are active against quinoline-resistant P. falciparum. ACS Chem. Biol. 9, 722-730. 1,2Equal contributions

Deane, K.J.1, Summers, R.L.1, Lehane, A.M., Martin, R.E.2 and Barrow, R.A.2 (2014) Chlorpheniramine analogues reverse chloroquine resistance in Plasmodium falciparum by inhibiting PfCRT. ACS Med. Chem. Lett. 5, 576-581. 1,2Equal contributions

Lehane, A.M., McDevitt, C.A., Kirk, K. and Fidock, D.A. (2012) Degrees of chloroquine resistance in malaria – is the redox system involved? Int. J. Parasitol. – Drugs and Drug Resistance 2, 47-57.

Ecker, A., Lehane, A.M., Clain, J. and Fidock, D.A. (2012) PfCRT and its role in antimalarial drug resistance. Trends Parasitol. 28, 504-514.

Ecker, A., Lehane, A.M. and Fidock, D.A. (2012) Molecular markers of Plasmodium resistance to antimalarials. In: Staines, H.M., Krishna, S. (Eds), Treatment and prevention of malaria: antimalarial drug chemistry, action and use. Birkhauser Verlag, Basel.

Lehane, A.M., van Schalkwyk, D.A., Valderramos, S.G., Fidock, D.A. and Kirk, K. (2011) Differential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparum strains expressing the same isoform of mutant PfCRT. Antimicrob. Agents Chemother. 55, 2310-2318.

Lehane, A.M. and Kirk, K. (2010) Efflux of a range of antimalarial drugs and ‘chloroquine resistance reversers’ from the digestive vacuole in malaria parasites with mutant PfCRT. Mol. Microbiol. 77, 1039-1051.

Henry, R.I., Cobbold, S.A., Allen, R.J., Khan, A., Hayward, R., Lehane, A.M., Bray, P.G., Howitt, S.M., Biagini, G.A., Saliba, K.J. and Kirk, K. (2010) An acid loading chloride transport pathway in the intraerythrocytic malaria parasite, Plasmodium falciparum. J. Biol. Chem. 285, 18615-18626.

Lehane, A.M., Hayward, R., Saliba K.J. and Kirk, K. (2008) A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites. J. Cell Sci. 121, 1624-1632.

Lehane, A.M. and Saliba, K.J. (2008) Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasite. BMC Research Notes 1, 26.

Lehane, A.M. and Kirk, K. (2008) Chloroquine resistance-conferring mutations in pfcrt give rise to a chloroquine-associated H+ leak from the malaria parasite’s digestive vacuole. Antimicrob. Agents Chemother. 52, 4374-4380.

Saliba, K.J., Lehane, A.M. and Kirk, K. (2008) A polymorphic drug pump in the malaria parasite. Mol. Microbiol. 70, 775-779.

Lehane, A.M., Marchetti, R.V., Spry, C., van Schalkwyk, D.A., Teng, R., Kirk, K and Saliba. K.J. (2007) Feedback inhibition of pantothenate kinase regulates pantothenol uptake by the malaria parasite. J. Biol. Chem. 282, 25395-25405.

Lehane, A.M., Korres, H. and Verma, N.K. (2005) Bacteriophage-encoded glucosyltransferase GtrII of Shigella flexneri: membrane topology and identification of critical residues. Biochem. J. 389, 137-143.

Lehane, A.M.1, Saliba, K.J.1, Allen, R.J.W. and Kirk, K. (2004) Choline uptake into the malaria parasite is energized by the membrane potential. Biochem. Biophys. Res. Comm. 320, 311-317. 1Joint first authors.

 

View all publications on the ANU Researchers website.

 

BIOL2174 - Cell Physiology in Health and Disease (Lecturer)